ClinVar Miner

Submissions for variant NM_000256.3(MYBPC3):c.1546G>A (p.Glu516Lys) (rs730880545)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000158099 SCV000208034 uncertain significance not provided 2014-05-13 criteria provided, single submitter clinical testing p.Glu516Lys (GAG>AAG): c.1546 G>A in exon 17 of the MYBPC3 gene (NM_000256.3). A variant of unknown significance has been identified in the MYBPC3 gene. The E516K variant has not been published as a mutation or as a benign polymorphism to our knowledge. The E516K variant was not observed in approximately 6400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations The E516K variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals and class conserved across species. Missense mutations in nearby residues (G507R, A522T) have been reported in association with HCM, supporting the functional importance of this region of the protein. Nevertheless, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. Mutations in the MYBPC3 gene have been reported in 20%-30% of patients with autosomal dominant familial HCM, and have been reported less frequently in patients with autosomal dominant familial DCM (CirinoAet al., 2011; Hershberger R et al., 2009). The variant is found in CARDIOMYOPATHY panel(s).
Ambry Genetics RCV000618008 SCV000737375 uncertain significance Cardiovascular phenotype 2016-09-09 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Insufficient evidence

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.